Fig. 2From: Impact of myelofibrosis on patients with myelodysplastic syndromes following allogeneic hematopoietic stem cell transplantationClinical outcomes of the whole cases with MDS after transplantation in the MF-0/1 and MF-2/3 cohorts (N = 153). A Cumulative incidence rate of grade II–IV acute GVHD. B Cumulative incidence rate of grade III–IV acute GVHD. C Cumulative incidence rate of moderate-to-severe chronic GVHD. D Cumulative incidence rate of relapse. E Cumulative incidence rate of NRM. F OS probabilities. G PFS probabilitiesBack to article page